mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.07 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.07 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.07 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.07 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.08 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.08 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.08 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.08 |